Sonire Therapeutics - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $79,679.03 +4.66%
Ethereum $3,207.83 +5.92%
BNB $638.00 +2.72%
Optimism $1.70 +6.40%
Arbitrum $0.64 +7.61%
Solana $209.97 +6.47%
Polygon $0.41 +9.07%
Cosmos $5.42 +15.76%
Avalanche $32.28 +12.08%

Bitcoin $79,679.03 +4.66%
Ethereum $3,207.83 +5.92%
BNB $638.00 +2.72%
Optimism $1.70 +6.40%
Arbitrum $0.64 +7.61%
Solana $209.97 +6.47%
Polygon $0.41 +9.07%
Cosmos $5.42 +15.76%
Avalanche $32.28 +12.08%

Sonire Therapeutics

company

Summary
Funding Rounds
Investors

About

Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.

11 - 50

Highlights

Total Funding Amount

Details

Last Funding Type: Series A
Last Funding Money Raised: ¥530M
Industries: Biotechnology,Health Care,Health Diagnostics,Medical,Wellness
Founded date: Feb 1, 2020
Number Of Employee: 11 - 50
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

¥530M

Sonire Therapeutics has raised a total of ¥530M in funding over 2 rounds. Their latest funding was raised on Jun 11, 2021 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 11, 2021	Series A	¥530M	1	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

1

Sonire Therapeutics is funded by 1 investors. Higin Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Higin Capital	—	Series A